Matches in Wikidata for { <http://www.wikidata.org/entity/Q91196540> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q91196540 description "article scientifique publié en 2019" @default.
- Q91196540 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q91196540 description "scientific article published on 21 October 2019" @default.
- Q91196540 description "wetenschappelijk artikel" @default.
- Q91196540 description "наукова стаття, опублікована 21 жовтня 2019" @default.
- Q91196540 name "Severe asthma phenotypes in patients controlled with omalizumab: A real-world study" @default.
- Q91196540 name "Severe asthma phenotypes in patients controlled with omalizumab: A real-world study" @default.
- Q91196540 type Item @default.
- Q91196540 label "Severe asthma phenotypes in patients controlled with omalizumab: A real-world study" @default.
- Q91196540 label "Severe asthma phenotypes in patients controlled with omalizumab: A real-world study" @default.
- Q91196540 prefLabel "Severe asthma phenotypes in patients controlled with omalizumab: A real-world study" @default.
- Q91196540 prefLabel "Severe asthma phenotypes in patients controlled with omalizumab: A real-world study" @default.
- Q91196540 P1433 Q91196540-115854F9-52E8-47E7-BC0C-8BB4D1A4624B @default.
- Q91196540 P1476 Q91196540-2D3F89CF-2C6E-4D6E-BEFB-E6A4949A9AF3 @default.
- Q91196540 P2093 Q91196540-3C1FA9B3-422F-4771-8BDA-6839E2424205 @default.
- Q91196540 P2093 Q91196540-47A9945E-0C61-4064-A9C7-CE7010FCC555 @default.
- Q91196540 P2093 Q91196540-6E2A3870-F3AC-40DD-BE2F-22BF76777FB0 @default.
- Q91196540 P2093 Q91196540-8D3960A7-C634-4D02-BA52-27D3F993C2A9 @default.
- Q91196540 P2093 Q91196540-FE24D127-4DD7-470D-B690-5654CECB8CBF @default.
- Q91196540 P2860 Q91196540-DB295E11-DB5D-42E3-B0A6-F48AE2801CEF @default.
- Q91196540 P304 Q91196540-8C49C1E4-4E7F-49F2-B353-117D33D02A7D @default.
- Q91196540 P31 Q91196540-055BDF97-85BC-44A4-9FC5-B84C95B7BCA7 @default.
- Q91196540 P356 Q91196540-8975639F-7603-4A37-8064-6939135A4650 @default.
- Q91196540 P478 Q91196540-E9F7E77E-407E-4FEE-BD0D-CC37523A65C8 @default.
- Q91196540 P50 Q91196540-40C66724-1280-4BA3-A91C-4ACE0C47A2CF @default.
- Q91196540 P50 Q91196540-545F6661-3948-439D-9796-51B0E1336903 @default.
- Q91196540 P577 Q91196540-E63837CF-476F-4A66-A72F-E0F712025B42 @default.
- Q91196540 P698 Q91196540-391F851D-A0C9-4CEE-9692-FAD07301A8A3 @default.
- Q91196540 P921 Q91196540-0E9DB5C9-5508-4469-BBF2-3B986E6D9B3A @default.
- Q91196540 P356 J.RMED.2019.105804 @default.
- Q91196540 P698 31704593 @default.
- Q91196540 P1433 Q2659932 @default.
- Q91196540 P1476 "Severe asthma phenotypes in patients controlled with omalizumab: A real-world study" @default.
- Q91196540 P2093 "Ana Moreira Jorge" @default.
- Q91196540 P2093 "Héctor Manuel González Expósito" @default.
- Q91196540 P2093 "Marina Blanco Aparicio" @default.
- Q91196540 P2093 "Paloma Campo" @default.
- Q91196540 P2093 "Santiago Quirce" @default.
- Q91196540 P2860 Q77199721 @default.
- Q91196540 P304 "105804" @default.
- Q91196540 P31 Q13442814 @default.
- Q91196540 P356 "10.1016/J.RMED.2019.105804" @default.
- Q91196540 P478 "159" @default.
- Q91196540 P50 Q42293380 @default.
- Q91196540 P50 Q57334718 @default.
- Q91196540 P577 "2019-10-21T00:00:00Z" @default.
- Q91196540 P698 "31704593" @default.
- Q91196540 P921 Q35869 @default.